KIOVIG

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug KIOVIG contains one active pharmaceutical ingredient (API):

1 Immunoglobulins, normal human, IV

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects.

Read about Immunoglobulins, normal human, IV

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
KIOVIG Solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J06BA02 Immunoglobulins, normal human, for intravascular adm. J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 501121010032217, 501121010032317, 501121010032417, 501121010032517, 501121010032617, 540218090001417, 540218090001517
Country: EE Ravimiamet Identifier(s): 1235449, 1235450, 1235461, 1235472, 1235483, 1476996
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 05329003, 05329004, 05329005
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 049902, 049913, 049925, 049936, 049947, 562577
Country: FR Base de données publique des médicaments Identifier(s): 67898029
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 171719, 171721, 171723, 171726, 171728, 332216
Country: HK Department of Health Drug Office Identifier(s): 56576
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7133, 7134
Country: IT Agenzia del Farmaco Identifier(s): 037107012, 037107024, 037107036, 037107048, 037107051, 037107063
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029326, 1029327, 1029328, 1029329, 1029330, 1056101
Country: NL Z-Index G-Standaard, PRK Identifier(s): 80039, 80047, 80055, 80063, 80071, 94242
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100155403
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66549001, W66549002, W66549003, W66549004, W66549005
Country: SG Health Sciences Authority Identifier(s): 13809P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 10623061H, 10623062H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681429550172, 8681429550189, 8681429550196, 8681429550202, 8681429550219

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.